
Gated Content Access Form - App Note
In the rapidly evolving field of cellular engineering, achieving complex gene edits with high efficiency and minimal workflow disruption remains a significant challenge. CellFE has developed a novel hybrid workflow combined with the use of Syenex virus that leverages the strengths of nonviral gene editing and viral transduction to overcome these challenges. This approach leverages CellFE’s delivery technology to complement Syenex’s next-generation T cell vector system (“SNX-T1”). The integrated approach couples nonviral knockout (KO) with viral knockin (KI) to create a highly efficient, single-day workflow for complex gene editing..